vs

Side-by-side financial comparison of CME Group (CME) and PLEXUS CORP (PLXS). Click either name above to swap in a different company.

CME Group is the larger business by last-quarter revenue ($1.9B vs $1.2B, roughly 1.6× PLEXUS CORP). PLEXUS CORP runs the higher net margin — 4.3% vs 0.1%, a 4.2% gap on every dollar of revenue. On growth, PLEXUS CORP posted the faster year-over-year revenue change (18.7% vs 14.5%). Over the past eight quarters, CME Group's revenue compounded faster (10.8% CAGR vs 7.2%).

CME Group Inc. is an American financial services company based in Chicago, Illinois. It operates financial derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX), and the Commodity Exchange (COMEX). The company owns 27% of S&P Dow Jones Indices. It is the world's largest operator of financial derivatives exchanges. Its exchanges are platforms for trading in agricultural products, currencies, energy, i...

Plex Systems, Inc. is an American software company based in Troy, Michigan. The company develops and markets the Plex Manufacturing Cloud, a software as a service (SaaS) or cloud computing ERP for manufacturing.

CME vs PLXS — Head-to-Head

Bigger by revenue
CME
CME
1.6× larger
CME
$1.9B
$1.2B
PLXS
Growing faster (revenue YoY)
PLXS
PLXS
+4.3% gap
PLXS
18.7%
14.5%
CME
Higher net margin
PLXS
PLXS
4.2% more per $
PLXS
4.3%
0.1%
CME
Faster 2-yr revenue CAGR
CME
CME
Annualised
CME
10.8%
7.2%
PLXS

Income Statement — Q1 FY2026 vs Q2 FY2026

Metric
CME
CME
PLXS
PLXS
Revenue
$1.9B
$1.2B
Net Profit
$1.2M
$49.8M
Gross Margin
10.2%
Operating Margin
0.1%
5.3%
Net Margin
0.1%
4.3%
Revenue YoY
14.5%
18.7%
Net Profit YoY
20.7%
27.5%
EPS (diluted)
$1.82

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CME
CME
PLXS
PLXS
Q1 26
$1.9B
$1.1B
Q4 25
$1.6B
Q3 25
$1.5B
Q2 25
$1.7B
Q1 25
$1.6B
Q4 24
$1.5B
Q3 24
$1.6B
Q2 24
$1.5B
Net Profit
CME
CME
PLXS
PLXS
Q1 26
$1.2M
$41.2M
Q4 25
$1.2B
Q3 25
$908.0M
Q2 25
$1.0B
Q1 25
$956.2M
Q4 24
$874.6M
Q3 24
$912.8M
Q2 24
$883.2M
Gross Margin
CME
CME
PLXS
PLXS
Q1 26
9.9%
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Operating Margin
CME
CME
PLXS
PLXS
Q1 26
0.1%
5.1%
Q4 25
61.8%
Q3 25
63.3%
Q2 25
66.7%
Q1 25
67.5%
Q4 24
62.1%
Q3 24
64.6%
Q2 24
65.3%
Net Margin
CME
CME
PLXS
PLXS
Q1 26
0.1%
3.8%
Q4 25
71.7%
Q3 25
59.1%
Q2 25
60.6%
Q1 25
58.2%
Q4 24
57.3%
Q3 24
57.6%
Q2 24
57.6%
EPS (diluted)
CME
CME
PLXS
PLXS
Q1 26
$1.51
Q4 25
$3.24
Q3 25
$2.49
Q2 25
$2.81
Q1 25
$2.62
Q4 24
$2.40
Q3 24
$2.50
Q2 24
$2.42

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CME
CME
PLXS
PLXS
Cash + ST InvestmentsLiquidity on hand
$2.4B
$303.1M
Total DebtLower is stronger
$3.4B
Stockholders' EquityBook value
$1.5B
Total Assets
$202.0B
$3.4B
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CME
CME
PLXS
PLXS
Q1 26
$2.4B
$248.8M
Q4 25
$4.5B
Q3 25
$2.6B
Q2 25
$2.1B
Q1 25
$1.5B
Q4 24
$3.0B
Q3 24
$2.4B
Q2 24
$1.9B
Total Debt
CME
CME
PLXS
PLXS
Q1 26
$3.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
CME
CME
PLXS
PLXS
Q1 26
$1.5B
Q4 25
$28.7B
Q3 25
$28.2B
Q2 25
$27.7B
Q1 25
$27.0B
Q4 24
$26.5B
Q3 24
$28.2B
Q2 24
$27.6B
Total Assets
CME
CME
PLXS
PLXS
Q1 26
$202.0B
$3.2B
Q4 25
$198.4B
Q3 25
$187.1B
Q2 25
$179.9B
Q1 25
$157.8B
Q4 24
$137.4B
Q3 24
$137.8B
Q2 24
$123.4B

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CME
CME

Segment breakdown not available.

PLXS
PLXS

Asia-Pacific$652.0M56%
Americas$397.0M34%
Europe, Middle East and Africa$116.0M10%

Related Comparisons